/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

K

Kenneth B. Gordon

Medical College of Wisconsin(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

309

Papers

25.5K

Citations

73

h-index

165

i10-index

Kenneth B. Gordon is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Psoriasis: Treatment and Pathogenesis & Dermatology and Skin Diseases & Autoimmune Bullous Skin Diseases. The author has an h-index of 73, co-authored 263 publications.

ORCID: 0000-0002-9347-0292

Research Topics

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Autoimmune Bullous Skin Diseases Asthma and respiratory diseases Health Systems, Economic Evaluations, Quality of Life

Papers by this author

works

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

2008 · The Lancet · 1,852 citations

https://doi.org/10.1016/s0140-6736(08)60725-4

Craig L. Leonardi Alexa B. Kimball Kim Papp Newman Yeilding

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

2018 · The Lancet · 627 citations

https://doi.org/10.1016/s0140-6736(18)31713-6

Kenneth B. Gordon Bruce Strober Mark Lebwohl Matthias Augustin

IFN-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells

1997 · The Journal of Immunology · 152 citations

https://doi.org/10.4049/jimmunol.158.2.614

Kelly M. Nikcevich Kenneth B. Gordon Litjen Tan Stephen D. Hurst

Presentation of Proteolipid Protein Epitopes and B7-1-Dependent Activation of Encephalitogenic T Cells by IFN-γ-Activated SJL/J Astrocytes

1998 · The Journal of Immunology · 95 citations

https://doi.org/10.4049/jimmunol.160.9.4271

Litjen Tan Kenneth B. Gordon John P. Mueller Louis A. Matis

Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study

2023 · The Lancet Rheumatology · 92 citations

https://doi.org/10.1016/s2665-9913(23)00034-6

Shikha Singla Michael Putman Jean W. Liew Kenneth B. Gordon

Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials

2019 · Journal of the American Academy of Dermatology · 89 citations

https://doi.org/10.1016/j.jaad.2019.11.040

Kristian Reich C.E.M. Griffiths Kenneth B. Gordon Kim Papp

Research topics

topics

Psoriasis: Treatment and Pathogenesis

Dermatology and Skin Diseases

Autoimmune Bullous Skin Diseases

Asthma and respiratory diseases

Health Systems, Economic Evaluations, Quality of Life

Chat about Author

Papers

Chat

Click to start Chat